Overview

Terlipressin for Refractory Septic Shock

Status:
Recruiting
Trial end date:
2025-07-31
Target enrollment:
Participant gender:
Summary
Norepinephrine was recommended as the first vasopressor for septic shock resuscitation. For the patient who did not response to high dose norepinephrine, epinephrine was recommended. Vasopressin was also recommended as an alternative vasopressor, in case patient did not response to norepinephrine and or epinephrine. Terlipressin, a selective V1 receptor binding with long half life, was reported that it main action is to increase blood pressure via the different mechanism from norepinephrine and epinephrine. To use terlipressin, combine with norepinephrine and or epinephrine among refractory septic shock, could decrease the usage dose of norepinephrine and epinephrine as well as lower the side effects of too high adrenergic stimuli.
Phase:
Phase 2
Details
Lead Sponsor:
Mahidol University
Treatments:
Epinephrine
Epinephryl borate
Norepinephrine
Racepinephrine
Terlipressin